Recent Finacing
Recent Raise
Rubius Therapeutics develops Red-Cell Therapeutics—genetically engineered, enucleated allogeneic red blood cells manufactured at clinical scale to deliver or present therapeutic proteins for enzyme deficiencies, cancer, autoimmune and metabolic diseases.
